Refsum's Disease--Use of the Intestinal Lipase Inhibitor, Orlistat, as a Novel Therapeutic Approach to a Complex Disorder.

Autor: Perera, Nimalie J.1, Lewis, Barry2, Tran, Huy3, Fietz, Michael4,5, Sullivan, David R.1 david.sullivan@sswahs.nsw.gov.au
Zdroj: Journal of Obesity. 2011, Vol. 2011, Special section p1-5. 5p. 1 Color Photograph, 1 Diagram, 1 Graph.
Databáze: Academic Search Ultimate